Crossmark

Genetic deletion of muscle RANK or selective inhibition of RANKL is not as effective as full-length OPG-fc in mitigating muscular dystrophy

Crossref DOI link: https://doi.org/10.1186/s40478-018-0533-1

Published Online: 2018-04-24

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dufresne, Sébastien S.

Boulanger-Piette, Antoine

Bossé, Sabrina

Argaw, Anteneh

Hamoudi, Dounia

Marcadet, Laetitia

Gamu, Daniel

Fajardo, Val A.

Yagita, Hideo

Penninger, Josef M.

Russell Tupling, A.

Frenette, Jérôme
Funding

Funding for this research was provided by:

Natural Sciences and Engineering Research Council of Canada (RGPIN 2016-05845)

Institute of Musculoskeletal Health and Arthritis (JNM 123675)

Jesse´s Journey

Duchenne Alliance
License Information

Text and Data Mining valid from 2018-04-24
More Information

Article History

Received: 8 March 2018

Accepted: 10 April 2018

First Online: 24 April 2018

Competing interests

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.